









市場行情
/
股票
/
nasdaq-clpt
/

Clearpoint Neuro Inc

CLPT

14.020USD

-0.470-3.24%

收盤 12/26, 16:00（美東）報價延遲15分鐘

398.56M總市值

虧損本益比TTM



Clearpoint Neuro Inc

14.020

-0.470-3.24%

概覽公司財務分析

概覽

公司

財務

分析

關於 Clearpoint Neuro Inc 公司

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Clearpoint Neuro Inc簡介



公司代碼CLPT

公司名稱Clearpoint Neuro Inc

上市日期Jul 03, 2019

CEOBurnett (Joseph Michael)

員工數量115

證券類型Ordinary Share

年結日Jul 03

公司地址120 S. Sierra Avenue

城市SOLANA BEACH

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編92075

電話19499006833

網址https://www.clearpointneuro.com/

公司代碼CLPT

上市日期Jul 03, 2019

CEOBurnett (Joseph Michael)

Clearpoint Neuro Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph Michael Burnett

President, Chief Executive Officer, Director

276.08K

-4.84%

Mr. Timothy T. Richards

Independent Director

78.87K

+0.71%

Dr. Matthew B. Klein, M.D.

Independent Director

50.52K

+71.68%

Mr. Mazin Sabra

Chief Operating Officer

44.08K

-14.51%

Ms. Lynnette C. Fallon

Independent Director

40.90K

-19.96%

Mr. Danilo D' Alessandro

Chief Financial Officer

Ms. B. Kristine (Kris) Johnson

Independent Director

Dr. Linda M. Liau

Independent Director

Mr. Jeremy L. Stigall

Chief Business Officer

Mr. R. John Fletcher

Independent Chairman of the Board

名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph Michael Burnett

President, Chief Executive Officer, Director

276.08K

-4.84%

Mr. Timothy T. Richards

Independent Director

78.87K

+0.71%

Dr. Matthew B. Klein, M.D.

Independent Director

50.52K

+71.68%

Mr. Mazin Sabra

Chief Operating Officer

44.08K

-14.51%

Ms. Lynnette C. Fallon

Independent Director

40.90K

-19.96%

Mr. Danilo D' Alessandro

Chief Financial Officer

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Products: Functional neurosurgery

3.43M

37.24%

Services: Biologics and drug delivery

2.87M

31.12%

Products: Biologics and drug delivery

1.87M

20.30%

Product Systems and software products

694.00K

7.53%

Services: Capital equipment and other

350.00K

3.80%

地區USD

名稱

營收

佔比

United States

9.21M

100.00%

業務

地區

業務USD

名稱

營收

佔比

Products: Functional neurosurgery

3.43M

37.24%

Services: Biologics and drug delivery

2.87M

31.12%

Products: Biologics and drug delivery

1.87M

20.30%

Product Systems and software products

694.00K

7.53%

Services: Capital equipment and other

350.00K

3.80%

股東統計

更新時間: 11月18日週二

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

5.47%

The Vanguard Group, Inc.

5.03%

Bigger Capital Funds, LP

4.34%

PTC Therapeutics Inc

3.01%

Geode Capital Management, L.L.C.

2.21%

其他

79.94%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

5.47%

The Vanguard Group, Inc.

5.03%

Bigger Capital Funds, LP

4.34%

PTC Therapeutics Inc

3.01%

Geode Capital Management, L.L.C.

2.21%

其他

79.94%

股東類型

持股股東

佔比

Investment Advisor

20.66%

Investment Advisor/Hedge Fund

9.97%

Hedge Fund

7.85%

Individual Investor

4.98%

Corporation

3.01%

Research Firm

1.38%

Bank and Trust

0.10%

Pension Fund

0.03%

Insurance Company

0.02%

其他

52.01%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

238

11.91M

42.82%

-795.00

2025Q3

241

11.91M

44.93%

+805.07K

2025Q2

228

11.11M

37.29%

+1.29M

2025Q1

216

9.82M

36.04%

-268.85K

2024Q4

204

9.20M

33.04%

+1.04M

2024Q3

190

8.15M

32.05%

-235.56K

2024Q2

185

8.39M

33.08%

-454.38K

2024Q1

183

8.85M

30.95%

+359.48K

2023Q4

183

7.82M

35.41%

+717.11K

2023Q3

184

7.11M

35.71%

+336.40K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

1.50M

5.27%

+1.13M

+307.45%

Jun 30, 2025

The Vanguard Group, Inc.

1.48M

5.19%

+191.14K

+14.89%

Jun 30, 2025

Bigger Capital Funds, LP

1.17M

4.1%

+31.67K

+2.79%

Jun 30, 2025

PTC Therapeutics Inc

894.58K

3.15%

Aug 23, 2024

Geode Capital Management, L.L.C.

624.80K

2.2%

+323.43K

+107.32%

Jun 30, 2025

State Street Investment Management (US)

333.38K

1.17%

+207.53K

+164.91%

Jun 30, 2025

Bigger (Michael)

378.69K

1.33%

Jun 30, 2025

Brown Advisory

330.90K

1.16%

-191.00

-0.06%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

1.19%

iShares Neuroscience and Healthcare ETF

0.94%

iShares Micro-Cap ETF

0.12%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.09%

Vanguard US Momentum Factor ETF

0.06%

Motley Fool Next Index ETF

0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

0.03%

iShares Russell 2000 Growth ETF

0.03%

iShares Russell 2000 ETF

0.02%

Proshares Ultra Russell 2000

0.02%

Invesco NASDAQ Future Gen 200 ETF

佔比1.19%

iShares Neuroscience and Healthcare ETF

佔比0.94%

iShares Micro-Cap ETF

佔比0.12%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.09%

Vanguard US Momentum Factor ETF

佔比0.06%

Motley Fool Next Index ETF

佔比0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

佔比0.03%

iShares Russell 2000 Growth ETF

佔比0.03%

iShares Russell 2000 ETF

佔比0.02%

Proshares Ultra Russell 2000

佔比0.02%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Clearpoint Neuro Inc的前五大股東是誰？



Clearpoint Neuro Inc的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：1.50M
佔總股份比例：5.27%。
The Vanguard Group, Inc.
持有股份：1.48M
佔總股份比例：5.19%。
Bigger Capital Funds, LP
持有股份：1.17M
佔總股份比例：4.10%。
PTC Therapeutics Inc
持有股份：894.58K
佔總股份比例：3.15%。
Geode Capital Management, L.L.C.
持有股份：624.80K
佔總股份比例：2.20%。